Codex @codex  0

A suitable historical answer gives both the chemical transformation and the means of isolating a reasonably pure product. The following are preparative principles, with modern chemical formulas; they are not instructions for self-preparation of medicines. In particular, hydrogen cyanide, mercury compounds and arsenic compounds present serious toxicity hazards. Hydrogen cyanide is extremely volatile, can be absorbed by several routes, and its odour is an unreliable warning.^[ref]

For hydrocyanic acid, a customary early nineteenth-century route is the controlled distillation of potassium ferrocyanide with dilute sulfuric acid and water. Hydrogen cyanide passes into the distillate; nonvolatile salts remain behind. A generating flask, efficient laboratory condenser and chilled receiver are needed because hydrogen cyanide is readily lost. The contemporary account of hydrocyanic acid preparation in Pharmacopoeia Castrensis Ruthenica in The British and Foreign Medical Review (1842) specifically describes the ferrocyanide–sulfuric acid method and its losses on imperfect condensation. The concentration must be determined analytically before any defined dilution: a nominal starting mixture does not establish the final strength.^[ref] At the level of the released cyanide, the essential acid-base reaction is $\mathrm{C}{\mathrm{N}}^{-}+{\mathrm{H}}^{+}\to \mathrm{HCN}$. This equation alone is not a complete equation for decomposing the stable ferrocyanide coordination complex. Concentrated sulfuric acid can lead to different decomposition chemistry, so the specified dilution is meaningful.

For formic acid, gently heat oxalic acid with glycerol and some water, then separate the aqueous formic acid by distillation. The useful net transformation isThe glycerol participates through intermediate esters and is regenerated rather than consumed in this net equation. Marcellin Berthelot's 1856 account describes the carbon dioxide evolution, subsequent water addition and distillation, and reuse of the residual glycerol. Overheating is disadvantageous because the formic acid can decompose further to carbon monoxide and water. The method therefore separates a volatile acid from a much less volatile carrier; it is not merely the dry destructive heating of oxalic acid.^[ref]

For oxalic acid, oxidize a carbohydrate, such as sucrose or starch, with nitric acid; concentrate the resulting chemical solution appropriately and cool it to obtain crystals, followed by recrystallization. Nitrogen oxides evolve, and excessive oxidation can carry carbon onward to carbon dioxide, so an idealized single-product equation would conceal losses. The use of starch and nitric acid for oxalic acid production is explicitly documented in an 1850 account of nitric oxide recovery.^[ref] An alternative already established before 1864 is alkaline treatment of sawdust, producing an oxalate which can be purified through sparingly soluble calcium oxalate.^[ref] Decomposing the isolated calcium oxalate with sulfuric acid separates much of the calcium as calcium sulfate:Filter off the calcium sulfate and crystallize the oxalic acid from the filtrate. The usual crystals contain two water of crystallization; a calculation for the anhydrous acid must not treat their entire mass as ${\mathrm{H}}_2{\mathrm{C}}_2{\mathrm{O}}_4$.

For calomel, intimately combine mercury(II) sulfate, metallic Mercury and dry sodium chloride, then collect the volatile mercury(I) chloride in a cooler receiving chamber. The net change isThe extra metallic Mercury lowers the average oxidation state from +2 to +1. The product is purified by appropriate sublimation and washing to remove soluble contamination, particularly mercury(II) chloride. Both the chemical composition and the fine subdivision of the product matter: condensation through a chamber can give a powder rather than an adherent crystalline crust. This physical part of calomel preparation is described in the 1843 primary account in Polytechnisches Journal volume 87 (1843); the account's historical therapeutic claims are not adopted here.^[ref]

For corrosive sublimate, heat dry mercury(II) sulfate with sodium chloride and collect the mercury(II) chloride in the cooler part of a suitable sublimation apparatus:Here no metallic Mercury is added. Nonvolatile sodium sulfate stays behind, while mercury(II) chloride is transferred and condensed. Further sublimation or recrystallization separates impurities. ^[ref] The crucial distinction from calomel preparation is whether Mercury remains in the +2 oxidation state or is converted to +1.

For the solid called arsenious acid, roast an arsenic-bearing ore in air and collect the volatile arsenic trioxide in cooler chambers; purify by resublimation. The essential oxidation is represented byActual ores also contain other chemical elements, so their roasting equations and gaseous by-products depend on composition. A contemporary 1860 report describes roasting arseniferous ores, collecting the volatile arsenic trioxide in chambers and refining it by another sublimation. It also demonstrates that apparently good material could contain antimony(III) oxide: physical appearance alone does not establish purity.^[ref] The product intended here is dry $\mathrm{A}{\mathrm{s}}_2{\mathrm{O}}_3$; dissolving it does not make the bottled solid a pure crystalline hydrate ${\mathrm{H}}_3\mathrm{As}{\mathrm{O}}_3$.

For tartar emetic, react antimony(III) oxide with potassium hydrogen tartrate in water. A small amount of water first gives intimate contact in a paste; subsequent heating with more water completes formation of the soluble potassium antimony tartrate. Filter away unreacted insoluble matter and cool the clear filtrate to crystallize the product. This sequence is directly described in a January 1864 discussion of the newly issued British Pharmacopoeia, rather than inferred from its later editions.^[ref] In the traditional antimonyl notation the underlying reaction, before assigning crystal water of crystallization, isThis notation expresses the overall composition; tartrate coordination complexes and water of crystallization need the qualification given in 4. The historical pharmaceutical use of tartar emetic does not make it a safe contemporary emetic.^[ref]

For potassium chlorate, pass chlorine into hot concentrated potassium hydroxide. The disproportionation gives potassium chloride together with potassium chlorate:Concentration and cooling permit fractional crystallization of the much less soluble cold-water potassium chlorate, leaving much of the potassium chloride in the mother liquor; recrystallization improves purity. Cold dilute alkali instead favours hypochlorite, so the heating condition is essential. An economical contemporary manufacturing alternative uses hot calcium hydroxide and potassium chloride; the overall accounting isThe 1850 account in Polytechnisches Journal volume 118 (1850) describes a steam-heated stirred vessel and recovery by cooling, rather than an electrical manufacturing process introduced retrospectively.^[ref]

The seven named mixtures of the 1864 British Pharmacopoeia are Mistura Ammoniaci, Mistura Amygdalae, Mistura Creasoti, Mistura Cretae, Mistura Ferri Composita, Mistura Guaiaci and Mistura Scammonii. Their compositions are as follows; avoirdupois ounces are used for solids and fluid ounces for liquids.

The category is an official preparation name, not every possible bedside combination of medicines. Camphor water and acacia mucilage are not additional entries under Mistura: the 1864 names are Aqua Camphorae and Mucilago Acaciae. ^[ref]

The 1864 British Pharmacopoeia supplied mild rubefacients, blistering preparations and agents producing pustulation; these different degrees of injury were grouped under historical counterirritation. Redness of the skin demonstrates a local effect, not removal of inflammation from a distant organ. The following enumeration uses the preparations current for the 1865 examination.

Other official substances could destroy tissue, but a caustic used to destroy a particular lesion is conceptually different from a counterirritant applied to influence another site. Likewise belladonna and aconite applications were principally intended to relieve pain, not simply to create a competing skin inflammation. Modern treatment should address the diagnosed condition; a historical claim of revulsion cannot justify blistering over a diseased heart or lung. The period literature itself recognised absorption, urinary irritation and sloughing from cantharides. No present-day use of a particular regulated skin preparation makes these broad historical indications valid.^[ref]

For December 1865 the relevant official preparations are those of the 1864 British Pharmacopoeia; dose ranges must come from contemporary prescribing evidence, not be borrowed from later editions. The first edition specified identities and preparations without supplying a universal clinical dose for every article. The following are historical adult quantities from The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865), using its British entries rather than bracketed United States formulas. They are not current prescribing instructions or established safe limits. “Grain” is a unit of mass; “minim”, fluid drachm and fluid ounce are units of volume. One Imperial fluid drachm contains 60 minims, and one fluid ounce contains eight fluid drachms. A minim is not an arbitrary drop.^[ref]

For arsenic, distinguish the elemental substance from its medicinal compounds. The relevant series comprises Acidum Arseniosum, Liquor Arsenicalis, Sodae Arsenias, Liquor Sodae Arseniatis and Ferri Arsenias. The contemporary ranges are arsenic trioxide about 1/60–1/12 grain; arsenical solution 2–5 minims, occasionally 10; crystalline sodium arsenate 1/12–1/2 grain, or its dried salt 1/20–1/4 grain; its official solution 5–30 minims; ferrous arsenate 1/10–1/8 grain. Hydrated and dried salts cannot be exchanged grain for grain. The two official arsenical solutions each contain four grains of their specified ingredient per fluid ounce, but the ingredients are different. The solution of arsenic and mercury discussed alongside them was non-official, and Liquor Arsenici Hydrochloricus was an addition in 1867: neither belongs in an unqualified list of 1864 preparations.^[ref][ref]

For copper, the medicinal article is purified Cupri Sulphas, copper sulfate: 1/4–2 grains as a historical astringent or tonic, 5–8 grains as a historical emetic. An external solution was described as 1–10 grains or more per fluid ounce, depending on the intended local action. The anhydrous test reagent and copper compounds listed among analytical materials are not additional ordinary internal preparations. Neither the historical emetic use nor an external concentration authorises modern oral use.^[ref]

For opium, the contemporary monograph gives powdered opium and Extractum Opii, 1/4–3 grains or more; Extractum Opii Liquidum, Tinctura Opii and Vinum Opii, 4–40 minims or more; Tinctura Camphorae cum Opio, 1–2 fluid drachms. These are the author's reported ranges, not maxima. His summary table differs, listing 3–30 minims for liquid extract and 1/2–4 grains for powdered opium; that internal variation should remain visible rather than being converted into an invented single official limit.^[ref]

The compound oral opium preparations require their own quantities: Pilula Opii, 2 1/2 grains upwards; Pilula Plumbi cum Opio, 4–8 grains; Pulvis Cretae Aromaticus cum Opio, 10–60 grains; Pulvis Ipecacuanhae cum Opio, a reference quantity of 5 grains upwards; Pulvis Kino cum Opio, 10 grains upwards; Trochisci Opii, one to four lozenges. In the same order, the pill masses and powders contain approximately one part opium in 5, 8, 40, 10 and 20; each opium lozenge contains 1/10 grain. “Upwards” in the historical source does not establish a safe upper boundary: the required opium content, other ingredients and circumstances controlled the quantity. The lead-containing pill has an additional toxic constituent. Enema Opii supplies about one grain of opium in the official two-fluid-ounce enema; this is a rectal preparation, not an oral measure.^[ref]

The external opium preparations, Emplastrum Opii, Linimentum Opii and Unguentum Gallae cum Opio, have no ordinary swallowed dose. For completeness the official isolated alkaloid series was Morphiae Hydrochloras, Liquor Morphiae Hydrochloratis, Suppositoria Morphiae, Trochisci Morphiae and Trochisci Morphiae et Ipecacuanhae. The reported historical quantities are morphine hydrochloride, 1/8–1 grain; its solution, 20 minims to two fluid drachms in the monograph; one suppository containing 1/4 grain; either kind of morphine lozenge, one to four, each containing 1/36 grain. The summary table gives a narrower upper quantity of one fluid drachm for the solution. These large historical ranges must not be interpreted as safe for a person without opioid tolerance. The solution contains four grains per fluid ounce. Neither a morphine-acetate preparation added later nor a non-official compound confection should be substituted for this 1864 series.^[ref]

For belladonna, Extractum Belladonnae, 1/6–1 grain; Tinctura Belladonnae, 5–30 minims. Emplastrum Belladonnae, Linimentum Belladonnae and Unguentum Belladonnae are external preparations, not additional oral doses. The associated Atropia, Liquor Atropiae and Unguentum Atropiae likewise require their route to be stated: this author specifically discourages routine internal atropine administration and describes ophthalmic use of the solution. Its strength is four grains per fluid ounce; the ointment contains eight grains per ounce. These are historical formulation strengths, not a modern eye-drop or oral prescription. The atropine-sulfate series introduced in 1867 is not the 1864 series.^[ref]

For Strychnia, strychnine, the historical range was 1/32–1/8 grain; Liquor Strychniae, 5–15 minims, the solution containing four grains per fluid ounce. If the botanical preparations yielding the alkaloid are included, powdered nux vomica, 1–3 grains; Extractum Nucis Vomicae, 1/4–2 grains; Tinctura Nucis Vomicae, 10–30 minims. The American editor already warned that the two-grain extract quantity was very large and that more than half a grain commonly risked adverse effects. Keeping that qualification is more faithful than presenting the printed upper range as routine or safe.^[ref]

For cinchona bark, powdered yellow, pale or red bark, 10–60 grains; Decoctum Cinchonae Flavae and Infusum Cinchonae Flavae, 1–2 fluid ounces; Extractum Cinchonae Flavae Liquidum, 10–60 minims; Tinctura Cinchonae Flavae and Tinctura Cinchonae Composita, 1–2 fluid drachms. The associated Tinctura Quiniae Composita was given at 1–2 fluid drachms. The isolated official quinine sulfate, Quiniae Sulphas, was listed at 1–10 grains, with larger quantities discussed for particular intermittent fevers. Ferri et Quiniae Citras, the official iron-and-quinine preparation, was listed at 5–20 grains. Other cinchona alkaloids discussed as possible remedies do not thereby become official preparations. Strength in bark equivalents also does not guarantee a fixed amount of extracted quinine.^[ref]

These figures answer a historical materia medica question. Current drug safety requires the exact modern product, route, indication and patient factors; poisonous nineteenth-century “tonics” and emetics are not revived by accurate transcription of their period doses. Strychnine can cause severe painful convulsions; opioids can depress breathing; and inorganic arsenic is a toxic and carcinogenic exposure. Those facts undermine any reading of the historical numbers as a self-treatment schedule.^{[ref][ref][ref]}

TODO: Solutions d and e and their test observations are absent. Iodine and morphia are named testing targets, not reported positive findings.

Neither iodine in $d$ nor morphine in $e$ is established. “Morphia” is the historical name for morphine. The available task can nevertheless be explained as two distinct analytical investigations, using separate portions and reference preparations.

For $d$, first distinguish free iodine from iodide. A cool, freshly prepared starch solution gives a strong blue colour with accessible iodine under suitable conditions. Test the reagent by itself and beside a known iodine preparation, so that contamination or a failed reagent is not mistaken for an observation about $d$. The intense blue starch indication is documented in contemporary discussion of the 1864 British Pharmacopoeia.^[ref]

An absent direct blue response would not, by itself, exclude iodine present as iodide, or establish that the specimen contains no interfering material. If the task includes combined iodine, an appropriately controlled oxidation on a separate portion is needed to liberate testable iodine; the unoxidized and treated portions answer different questions. The response of the untreated specimen must not be confused with one deliberately produced by changing its chemical state. These are possible branches of the investigation, not observations supplied for $d$.

For $e$, use the period's chemical identity reactions as corroborating observations. The British Pharmacopoeia by the General Medical Council (1864) describes the response of hydrochlorate of morphia to iron(III) chloride and nitric acid: the former gives a blue indication under the specified conditions, and the latter an orange-red indication. The monograph is a reference for a defined material; it does not guarantee that every dilute or impure unknown will reproduce those colours.^[ref]

Use separate portions for the two tests and include a reagent blank and a known morphine reference. Acidity, concentration and other coloured or reactive constituents can affect interpretation. A single colour should therefore be treated as preliminary evidence rather than a conclusive identification in an unrestricted unknown. An unexplained failure of the known reference would invalidate the comparison, while a coloured blank would indicate a problem independent of $e$.

A completed practical record would give the actual response of each sample, reagent and reference, followed by an appropriately qualified conclusion. The reference behaviours explain the tests; they cannot supply the missing results for $d$ or $e$.

The required sequence is fresh flowers; sliced and dried bulb; unexpanded petals; heartwood; seeds; expressed seed fat; expressed seed oil; and fresh and dried root. The plant organ, its state, and the actual official material must all be specified.

The names in the paper sometimes use the shorter terminology of the first British Pharmacopoeia, whereas the 1867 edition explicitly renamed many entries to identify the medicinal organ. Its alteration list, for example, maps Sambucus to Sambuci flores, Pterocarpus to Pterocarpi lignum, and Taraxacum to Taraxaci radix.^[ref] That is a nomenclature change, not permission to choose any part of the named plant.

Ordinary cantharides blisters owe their activity to cantharidin; other blistering methods act through different chemical irritants or through physical injury. There is no single substance common to every way of raising a blister.

In the standard historical preparations, the dried blister beetle supplies cantharidin. A plaster, blistering paper, blistering liquid, or cantharides vinegar is a different vehicle for delivering the same vesicant to the skin. Extracting the beetle into a liquid does not make the solvent the specific active principle. The 1867 British Pharmacopoeia includes Emplastrum cantharidis, Charta epispastica, Liquor epispasticus and Acetum cantharidis.^[ref]

Other historical means need separate explanations. Moist mustard develops an irritant volatile product, principally allyl isothiocyanate from black mustard; its usual intended effect is reddening, with prolonged exposure capable of more destructive injury. This differs from the fixed mustard seed oil: the irritant volatile product develops after moistening the powdered seeds.^[ref] Strong Ammonia acts as an alkaline irritant. Croton oil can produce an inflammatory and pustular eruption, which is not the same lesion as a clean cantharides blister. A sufficiently hot object or hot liquid raises a blister through thermal damage, without a medicinal active molecule. These differences matter because erythema, a fluid-filled blister, a pustule, and tissue destruction are not interchangeable endpoints.

For cantharidin, the modern tissue explanation involves loss of adhesion between epidermal cells, including disruption of desmosomes, with separation within the epidermis and accumulation of fluid. The blister is therefore a local lesion of cell adhesion accompanied by inflammation, rather than a pocket containing disease drawn from a remote organ. The FDA review describes this acantholysis and distinguishes it from the incompletely understood mechanism of clinical benefit in a particular modern indication.^[ref]

A nineteenth-century answer would usually describe two supposed routes to benefit:

Thus the demonstrable processes are local injury, inflammation, fluid exudation, and sensory stimulation; the broad historical claims of remote benefit require separate evidence. Current approved topical cantharidin use for molluscum contagiosum does not validate nineteenth-century blistering for diseases of internal organs. The modern label explicitly states that the mechanism of action in molluscum contagiosum is unknown and documents local skin reactions.^[ref]